Alopecia Associated with HMG-CoA Reductase Inhibitor;“Delayed,Recurrent” SIADH and SSRIs;Serious Adverse Effects with Acetazolamide;Tetany Associated with Proton Pump Inhibitor
Restricted accessResearch articleFirst published online October, 2002
Alopecia Associated with HMG-CoA Reductase Inhibitor;“Delayed,Recurrent” SIADH and SSRIs;Serious Adverse Effects with Acetazolamide;Tetany Associated with Proton Pump Inhibitor
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
SegalA.S.Alopecia associated with atorvastatin [letter].Am J Med.2002; 113: 171.
ElinavE., AckermanZ., GottehrerN.P.Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic Type IV renal tubular acidosis [letter].Ann Emerg Med.2002; 40: 259–60.
4.
GalleraniM., ManzoliN., FellinR.Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide [letter].Am J Emerg Med.2002; 20: 371–2.
5.
SubbiahV., TayekJ.A.Tetany secondary to the use of a proton pump inhibitor [letter].Ann Intern Med.2002; 137: 218–9.
6.
Anon.Stedman's Medical Dictionary. 27th edition.Baltimore: Lippincott Williams & Wilkins; 2000, 1636.
